Schäfer, Ingmar https://orcid.org/0000-0002-1038-7478
Schulze, Josefine https://orcid.org/0000-0002-5727-9343
Glassen, Katharina https://orcid.org/0000-0002-8892-8625
Breckner, Amanda https://orcid.org/0000-0003-0777-5223
Hansen, Heike https://orcid.org/0000-0003-4901-3091
Rakebrandt, Anja https://orcid.org/0000-0002-1599-0188
Berg, Jessica
Blozik, Eva https://orcid.org/0000-0002-0620-6873
Szecsenyi, Joachim https://orcid.org/0000-0002-4483-0028
Lühmann, Dagmar https://orcid.org/0000-0001-7965-5007
Scherer, Martin
Funding for this research was provided by:
Gemeinsame Bundesausschuss (01VSF16058)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 20 January 2023
Accepted: 30 March 2023
First Online: 17 April 2023
Declarations
:
: Ethics approval was obtained from Ethics Committee of the Hamburg Medical Association on 10 September 2018 (file no. PV5846). All participants gave written informed consent prior to their participation in the study.
: Not applicable.
: MS, DL, IS and HH authored the DEGAM guideline on multimorbidity but have no other competing interests to declare. All other authors declare that they have no competing interests.